Eryzen
Generic Name
Erythromycin
Manufacturer
Square Pharmaceuticals Ltd.
Country
Bangladesh
Loading images...
Price Details
Current market pricing information
| Variant | Unit Price | Strip Price |
|---|---|---|
| eryzen 500 mg tablet | ৳ 8.66 | ৳ 34.64 |
Description
Overview of the medicine
Eryzen 500 mg Tablet contains Erythromycin, a macrolide antibiotic used to treat various bacterial infections including respiratory, skin, and genitourinary tract infections.
Uses & Indications
Dosage
Adults
250 mg to 500 mg every 6 to 12 hours, depending on the severity and type of infection. Maximum dose typically 4 g per day.
Elderly
Similar to adult dosage, but caution advised due to potential age-related decline in renal or hepatic function.
Renal_impairment
No major dose adjustment required for mild to moderate renal impairment. For severe impairment (CrCl <10 mL/min), consider reducing dose or increasing dosing interval.
How to Take
Eryzen 500 mg Tablet should be taken orally, preferably on an empty stomach (1 hour before or 2 hours after meals) with a glass of water for optimal absorption. If stomach upset occurs, it may be taken with food.
Mechanism of Action
Erythromycin binds to the 50S ribosomal subunit of susceptible bacteria, thereby inhibiting protein synthesis. This action is primarily bacteriostatic, but can be bactericidal at higher concentrations.
Pharmacokinetics
Onset
Peak plasma concentrations are usually reached within 1-4 hours after oral administration.
Excretion
Mainly excreted in the bile and feces; a small portion is excreted unchanged in the urine.
Half life
Approximately 1.5-2 hours in adults, with some variation.
Absorption
Well absorbed orally, though absorption may be decreased by food. Enteric-coated formulations minimize gastric degradation.
Metabolism
Primarily metabolized in the liver by the cytochrome P450 3A4 (CYP3A4) enzyme system.
Side Effects
Contraindications
- •Known hypersensitivity to erythromycin or any other macrolide antibiotics.
- •Co-administration with terfenadine, astemizole, cisapride, pimozide, or colchicine due to risk of serious and/or life-threatening cardiac arrhythmias (QT prolongation).
- •Patients with pre-existing liver disease or cholestatic jaundice.
Drug Interactions
Digoxin
Increased plasma levels of digoxin.
Warfarin
Increased anticoagulant effect, leading to bleeding risk.
Theophylline
Increased plasma levels of theophylline, leading to toxicity.
Statins (e.g., simvastatin, lovastatin)
Increased risk of myopathy, including rhabdomyolysis, due to CYP3A4 inhibition.
CYP3A4 Inhibitors (e.g., ketoconazole, protease inhibitors)
May increase erythromycin levels and risk of toxicity.
QT-prolonging drugs (e.g., Class IA and III antiarrhythmics)
Increased risk of cardiac arrhythmias.
Storage
Store below 30°C in a dry place, away from light and moisture. Keep out of reach of children.
Overdose
Symptoms of overdose include severe nausea, vomiting, abdominal pain, and diarrhea. Hepatic dysfunction and reversible hearing loss may also occur. Management involves gastric lavage, supportive care, and monitoring of vital signs and cardiac function. Erythromycin is not removed by peritoneal dialysis or hemodialysis.
Pregnancy & Lactation
Pregnancy Category B. Studies in animals have shown no evidence of harm to the fetus. Limited data in pregnant women suggest no increased risk of major congenital anomalies. Use during pregnancy only if clearly needed. Erythromycin is excreted in breast milk; use with caution in nursing mothers.
Frequently Asked Questions
Common questions about this medicine
Pack Sizes
Shelf Life
3 years from the date of manufacture.
Availability
Pharmacies, Hospitals
Approval Status
Approved
Patent Status
Generic/Off-patent
WHO Essential Medicine
YesAlternative Medicines in Bangladesh
Similar medicines available in the market
Global Brand Names
International brand names for this medicine
More Medicines
Explore other medicines you might be interested in


